Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Velano Vascular

Explore full profile

Needle-free blood collection device for inpatient care

San Francisco, United StatesFounded 2012Health Tech & Medtech
Valuation $50–100M Last recorded · 2019
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Velano Vascular and the history behind them.

About Velano Vascular

Velano Vascular, founded in 2012 by Eric M. Stone and Dr. Pitamber Devgon, developed a medical device to transform inpatient blood draws. The company's core product, PIVO (Push-in, Twist-off), is a needle-free blood collection device that attaches to an existing peripheral intravenous (IV) catheter, enabling practitioners to collect high-quality blood samples without a separate needle stick for each draw. This process aims to reduce patient pain and anxiety, particularly for those with difficult venous access or who require frequent testing, while also increasing practitioner safety.

The concept for Velano Vascular originated from the collaboration between Stone, a patient advocate diagnosed with Crohn's Disease as a teenager, and Dr. Devgon, an internal medicine physician. Stone's personal experience with frequent medical procedures and his background in healthcare marketing and business development, combined with Dr. Devgon's clinical perspective, drove the creation of a more compassionate approach to vascular access. Before co-founding Velano, Stone held positions at Abbott Laboratories and was a founding member of Model N's Life Sciences division. Dr. Devgon, the inventor of the patented technology, previously worked in venture capital at Safeguard Scientifics, focusing on medical device investments.

Velano Vascular's business model focused on selling the single-use, FDA-cleared PIVO device to hospitals and health systems. The company demonstrated the device's value by highlighting improved patient satisfaction, reduced procedural risks, and potential cost efficiencies. By making the existing IV line a reliable access point for blood collection, PIVO aimed to establish a "one-stick hospital stay" as a new standard of care. The company raised significant funding, over $51 million, from investors including First Round Capital, Kapor Capital, and major health systems like Intermountain Healthcare. In July 2021, Becton, Dickinson and Company (BD), a global medical technology company, acquired Velano Vascular to integrate the PIVO technology into its portfolio of vascular access and blood collection solutions.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2012
Headquarters
San Francisco, United States
Employees
17
Open positions
None listed
Dealroom signal
60.6/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Risk Management, Cardiology and cardiovascular, Health Diagnostics, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2c

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jul 2021 $0 — BD —
EARLY VCOther financing Dec 2019 $15M $60M Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Velano Vascular website traffic

Latest recorded traffic for Velano Vascular is 170 monthly website visits, down 77.9% over the last three months. Velano Vascular's team grew 0% over the past year.

Latest monthly visits170 3-month web change-77.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

Other known investors1 additional known investor

  • BD
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Velano Vascular on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Velano Vascular’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.